A clinical trial of inhaled inactivated influenza vaccine
Davies, J.E.; Howell, R.H.; Meichen, F.W.
British Journal of Clinical Practice 27(6): 219-221
1973
ISSN/ISBN: 0007-0947 PMID: 4582146 Document Number: 59201
Document emailed within 1 workday
Related Documents
Guo, W.; Xu, J.; Wu, J.; Zhao, S.; He, H.; Shi, W.; Yu, D.; Li, J.; Gao, H.; Chen, J. 2014: Safety and immunogenicity of seasonal inactivated influenza vaccine (split virion) and cross-reactive antibody responses to the H7N9 avian influenza virus Zhonghua Liu Xing Bing Xue Za Zhi 35(8): 949-952Petrescu, A.; Mihail, A.; Samuel, I.; Teodosiu, O.; Isaia, G.; Ganea, E.; Motaş, C. 1979: Neutralizing influenza antibodies, IgA and total protein in the nasopharyngeal secretions of subjects vaccinated by nasal route with the inactivated influenza vaccine prepared in the "Stefan S. Nicolau" Institute of Virology Virologie 30(2): 109-115
Xing, Y.; Liu, M. 2009: Meta analysis on the effectiveness of inactivated influenza vaccine Zhonghua Liu Xing Bing Xue Za Zhi 30(4): 368-370
Erofeeva, M.K.; Mel'nikov, S.I.; Semchenko, A.V.; Korovkin, S.A.; Nikonorov, I.I.; Maksakova, V.L.; Voĭtsekhovskaia, E.M.; Erman, E.S.; Gonchar, V.V.; Pozdeev, V.K.; Drinevskiĭ, V.P. 2010: Clinical trial of safety and immunogenicity of new influenza vaccine Grifor in children Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2: 55-59
Petrescu, A.L.; Cajal, N. 1984: Results obtained with the NIVGRIP inactivated influenza vaccine applicable by nasal and/or oral route Virologie 35(4): 307-314
Vasil'eva, R.I.; Osidak, L.V.; Bichurina, M.A.; Mukhina, L.P.; Chudina, L.V. 1982: Evaluation of the safety, reactogenicity and antigenic activity of inactivated chromatographic influenza vaccine in school children Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 4: 96-98
Rudenko, L.G.; Selivanov, A.A.; Ikramov, N.V.; Tsybul'skaia, N.V.; Ostrovskiĭ, A.D. 1984: Effect of repeated immunization with inactivated influenza vaccine on the formation of specific and nonspecific immunity factors Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 12: 98-101
Danielescu, G.; Barbu, C.; Sorodoc, Y.; Cajal, N.; Sărăteanu, D. 1975: The presence of interferon and type a immunoglobulins in the nasopharyngeal secretions of volunteers immunized with an inactivated influenza vaccine Acta Virologica 19(3): 245-249
Coutinho, R.A.; Lelie, P.N.; Albrecht-van Lent, P.; Stoutjesdijk, L.; Huisman, J.; Kuipers, H.; Schut, L.J.; Reerink-Brongers, E.E.; Reesink, H.W.; van Aken, W.G. 1983: Efficacy trial of heat-inactivated hepatitis B vaccine (CLB) in male homosexuals in the Netherlands Developments in Biological Standardization 54: 287-292
Oxford, J.S. 1991: Antigenic and biochemical studies of influenza viruses isolated in defined community epidemics have allowed the development of a new experimental inactivated vaccine Progress in Medical Virology. Fortschritte der Medizinischen Virusforschung. Progres en Virologie Medicale 38: 180-203
2000: Delayed supply of influenza vaccine and adjunct ACIP influenza vaccine recommendations for the 2000-01 influenza season. Advisory Committee on Immunization Practices Mmwr. Morbidity and Mortality Weekly Report 49(27): 619-622
Fedson, D.S.; Fulk, R.V.; Huber, M.A.; Reisberg, M.A.; Kasel, J.A. 1971: Anti-neuraminidase antibody response in serum and nasal secretions following intranasal or subcutaneous inactivated A2-Hong Kong-68 influenza virus vaccine Journal of Immunology 107(3): 730-737
Fine, M. 2004: The Rhode Island influenza vaccine experience 1995-2003: influenza vaccine price, reimbursement, availability, and Rhode Island's influenza vaccination rate Medicine and Health Rhode Island 87(3): 79-80
Kovalenko, V.N. 1971: Clinical effectiveness of inactivated cultural vaccine against tick-borne encephalitis and criteria for its evaluation Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 71(7): 1006-1011
Miura, S. 1968: Effects of the combined administration of a triple vaccine of pertussis, diphtheria and tetanus and virus vaccine (live polio vaccine or inactivated measles vaccine) on immunity to pertussis, diphtheria and tetanus. 1. Results of the initial immunization Nihon Shonika Gakkai Zasshi. Acta Paediatrica Japonica 72(6): 767-781
Wennerås, C.; Czerkinsky, C.; Svennerholm, A.M. 1995: Vaccine-specific T cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine Advances in Experimental Medicine and Biology 371b: 1641-1644
Desheva, Y.A.; Smolonogina, T.A.; Rudenko, L.G. 2015: A preclinical trial of the reassortant influenza virus vaccine strain A/17/Quail/Hong Kong/97/84 (H9N2) Voprosy Virusologii 60(4): 40-44
Murphey-Corb, M.; Martin, L.N.; Davison-Fairburn, B.; Montelaro, R.C.; Miller, M.; West, M.; Ohkawa, S.; Baskin, G.B.; Zhang, J.Y.; Putney, S. 1990: A formalin inactivated whole SIV vaccine and a glycoprotein-enriched subunit vaccine confers protection against experimental challenge with pathogenic live SIV in rhesus monkeys Developments in Biological Standardization 72: 273-285
Lin, T.-Y.; Wang, Y.-H.; Chang, L.-Y.; Chiu, C.-H.; Huang, Y.-C.; Tang, H.; Bock, H.L. 2003: Safety and immunogenicity of a diphtheria, tetanus, and acellular pertussis-inactivated poliovirus vaccine/Haemophilus influenzae type B combination vaccine administered to Taiwanese infants at 2, 4, and 6 months of age Chang Gung Medical Journal 26(5): 315-322
Shahzad, A.; Köhler, G. 2009: Inactivated Polio Vaccine (IPV): a strong candidate vaccine for achieving global polio eradication program Vaccine 27(39): 5293-5294